Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01014104

Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome

Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome in In-vitro Fertilization Cycles: A Randomized Controlled Trial

Sponsor: Royan Institute

Conditions Ovarian Hyperstimulation Syndrome

Interventions Control Methylprednisolone

Updated 6 times since 2017 Last updated: Jul 14, 2011 Started: Oct 31, 2009 Primary completion: Aug 31, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01014104, this PHASE1/PHASE2 trial focuses on Ovarian Hyperstimulation Syndrome and remains completed. Sponsored by Royan Institute, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royan Institute

Data source: Royan Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran